Logo

MediWound Ltd.

MDWD

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx… read more

Healthcare

Biotechnology

9 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$17.64

Price

-2.11%

-$0.38

Market Cap

$191.846m

Small

Price/Earnings

-

Premium

3y Avg

Premium

5y Avg

Financials Overview

Key metrics over the past few years

-

EBITDA Margin

-

Net Profit Margin

-

Free Cash Flow Margin
Revenue

$19.858m

-

1y CAGR

-

3y CAGR

-

5y CAGR
Earnings

-$28.234m

-

1y CAGR

-

3y CAGR

-

5y CAGR
EPS

-$2.64

-

1y CAGR

-

3y CAGR

-

5y CAGR
Book Value

$20.119m

$67.001m

Assets

$46.882m

Liabilities

$8.070m

Debt
Debt to Assets

12.0%

-0.3x

Debt to EBITDA
Free Cash Flow

-$19.265m

-

1y CAGR

-

3y CAGR

-

5y CAGR

Financial Reports

Earnings and other important metrics. Amounts in USD.
No items found.
Press Releases
Statements and updates from the company
↑ TopSummaryPriceFinancialsPress Releases